Cargando…
Pseudomonas aeruginosa Bloodstream Infections in Patients with Cancer: Differences between Patients with Hematological Malignancies and Solid Tumors
Objectives: To assess the clinical features and outcomes of Pseudomonas aeruginosa bloodstream infection (PA BSI) in neutropenic patients with hematological malignancies (HM) and with solid tumors (ST), and identify the risk factors for 30-day mortality. Methods: We performed a large multicenter, re...
Ejemplares similares
-
Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia
por: Albasanz-Puig, Adaia, et al.
Publicado: (2022) -
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study
por: Albasanz-Puig, Adaia, et al.
Publicado: (2019) -
Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospective observational study (BICAR)
por: Gudiol, C, et al.
Publicado: (2017) -
A fresh look at polymicrobial bloodstream infection in cancer patients
por: Royo-Cebrecos, Cristina, et al.
Publicado: (2017) -
Causes of Death in a Contemporary Cohort of Patients with Invasive Aspergillosis
por: Garcia-Vidal, Carolina, et al.
Publicado: (2015)